AcelRx Pharmaceuticals Inc
ACRX
|
|
| |
|
| Trading Volume | 100 |
|
|
1.50 - 0.45 |
| Market Cap Full | $ 15.8M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 14.7% | 40.1% | -70.9% | -48.2% |
| Q2 | - | -15.3% | 68.7% | -17.2% |
| Q3 | - | -6.1% | -47.8% | 1650% |
| Q4 | - | -40.3% | 33.6% | -46.2% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.7 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 41.5 | 30.8 | -24.3 | -1.9 | 3 | -13.7 | 10.2 | -6.1 | - | - | - | -29.2 |
| 2023 | |||||||||||
| -11.5 | -29 | -53.7 | 1.8 | 48.7 | 11.5 | -7.2 | - | -43.7 | -10.3 | 41.4 | - |
| 2022 | |||||||||||
| -15.5 | -4.7 | -35.7 | -13.8 | -8 | 4.4 | -12.5 | 40 | 1328.6 | -37.1 | -9.5 | -5.4 |
| 2021 | |||||||||||
| 77.4 | -14.6 | -9.6 | -23.5 | 6.9 | -0.7 | -14.5 | -5.1 | -8.9 | -12.7 | -28.4 | -12.2 |
| 2020 | |||||||||||
| -18 | -28.3 | -5.2 | 36.4 | -13.7 | -13 | -9.9 | 12.8 | 15.5 | 20.4 | -11.5 | -18.1 |
EPS
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Q1 | -1.2 | -0.1 | -0.2 |
| Q2 | 9.6 | -0.1 | -0.1 |
| Q3 | -0.9 | -0.1 | -0.1 |
| Q4 | -1.7 | -1.3 | -0.1 |
| A | 5.7 | -5.9 | -0.5 |